Effect of sub-chronic hydrocortisone on responses to amphetamine in normal male volunteers

Psychopharmacology

Volumn 171, Issue 4, 2004, Pages 458-464

  Hearn, Andrea J ^a   Gallagher, Peter ^a   Owen, Bruce M ^a   Smith, Margaret S ^a   Watson, Stuart ^a   Young, Allan H ^a,b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

Cortisol; Dopamine; Human; Hydrocortisone; Metamphetamine; Neuropsychological function; Prolactin

Indexed keywords

CENTRAL STIMULANT AGENT; CORTICOSTEROID; DOPAMINE; HYDROCORTISONE; METHAMPHETAMINE; PROLACTIN;

ADULT; ARTICLE; ATTENTION; BLOOD SAMPLING; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG POTENTIATION; HUMAN; HYDROCORTISONE BLOOD LEVEL; MALE; MENTAL TASK; MOOD DISORDER; NEUROENDOCRINE SYSTEM; NEUROMODULATION; NEUROPSYCHOLOGICAL TEST; NORMAL HUMAN; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; TASK PERFORMANCE; VISION TEST; VISUAL ANALOG SCALE; VISUAL INFORMATION;

ADOLESCENT; ADULT; AFFECT; AMPHETAMINE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; HUMANS; HYDROCORTISONE; MALE; PROLACTIN; REACTION TIME; SALIVA;

EID: 1042277052     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-003-1609-5     Document Type: Article

References (47)

1. Battaglia G, Napier TC (1998) The effects of cocaine and the amphetamines on brain and behavior: a conference report. Drug Alcohol Depend 52:41-48
2. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561-571
3. Bond A, Lader M (1974) The use of analogue scales in rating subjective feelings. Br J Med Psychol 47:211-218
4. Cervantes P, Gelber S, Kin F, Nair VNP, Schwartz G (2001) Circadian secretion of cortisol in bipolar disorder. J Psychiatry Neurosci 26:411-416
5. Creese I (1985) Dopamine and antipsychotic medications. In: Hales RE, Frances AJ (eds) Psychiatry update. American Psychiatric Press, Washington D.C., pp 17-36
6. de Kloet ER, Joels M, Oitzl M, Sutanto W (1991) Implication of brain corticosteroid receptor diversity for the adaptation syndrome concept. Meth Achiev Exp Pathol 14:104-132
7. Deuschle M, Schweiger U, Weber B, Gotthardt U, Korner A, Schmider J, Standhardt H, Lammers CH, Heuser I (1997) Diurnal activity and pulsatility of the hypothalamus-pituitary-adrenal system in male depressed patients and healthy controls. J Clin Endocrinol Metab 82:234-238
8. Dixon RB, Christy NP (1980) On the various forms of corticosteroid withdrawal syndrome. Am J Med 68:224-230
9. Elliott R, Sahakian BJ, Matthews K, Bannerjea A, Rimmer J, Robbins TW (1997) Effects of methylphenidate on spatial working memory and planning in healthy young adults. Psychopharmacology 131:196-206
10. Erb S, Shaham Y, Stewart J (1998) The role of corticotropin-releasing factor and corticosterone in stress-and cocaine-induced relapse to cocaine seeking in rats. J Neurosci 18:5529-5536
11. Goeders NE (2002) Stress and cocaine addiction. J Pharmacol Exp Ther 301:785-789
12. Grasby PM (2002) Imaging the neurochemical brain in health and disease. Clin Med 2:67-73
13. Harmer CJ, McTavish SF, Clark L, Goodwin GM, Cowen PJ (2001) Tyrosine depletion attenuates dopamine function in healthy volunteers. Psychopharmacology 154:105-111
14. Ikemoto S, Panksepp J (1999) The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to reward-seeking. Brain Res Brain Res Rev 31:6-41
15. King AC, Schluger J, Gunduz M, Borg L, Perret G, Ho A, Kreek MJ (2002) Hypothalamic-pituitary-adrenocortical (HPA) axis response and biotransformation of oral naltrexone: preliminary examination of relationship to family history of alcoholism. Neuropsychopharmacology 26:778-788
16. Koob GF, Le Moal M (2001) Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24:97-129
17. Koob GF, Caine B, Markou A, Pulvirenti L, Weiss F (1994) Role for the mesocortical dopamine system in the motivating effects of cocaine. NIDA Res Monogr 145:1-18
18. Kreek MJ, Koob GF (1998) Drug dependence: stress and dysregulation of brain reward pathways. Drug Alcohol Depend 51:23-47
19. Leitch MM, Ingram CD, Young AH, McQuade R, Gartside SE (2003) Flattening the corticosterone rhythm attenuates 5-HT(1A) autoreceptor function in the rat: relevance for depression. Neuropsychopharmacology 28:119-125
20. Lieberman HR, Wurtman RJ, Emde GG, Roberts C, Coviella IL (1987) The effects of low doses of caffeine on human performance and mood. Psychopharmacology 92:308-312
21. Ling MH, Perry PJ, Tsuang MT (1981) Side effects of corticosteroid therapy. Psychiatric aspects. Arch Gen Psychiatry 38:471-477
22. Marinelli M, Piazza PV (2002) Interaction between glucocorticoid hormones, stress and psychostimulant drugs. Eur J Neurosci 16:387-394
23. Matthews JN, Altman DG, Campbell MJ, Royston P (1990) Analysis of serial measurements in medical research. BMJ 300:230-235
24. McTavish SF, McPherson MH, Harmer CJ, Clark L, Sharp T, Goodwin GM, Cowen PJ (2001) Antidopaminergic effects of dietary tyrosine depletion in healthy subjects and patients with manic illness. Br J Psychiatry 179:356-360
25. Miczek KA, Mutschler NH (1996) Activational effects of social stress on IV cocaine self-administration in rats. Psychopharmacology 128:256-264
26. Pani L, Porcella A, Gessa GL (2000) The role of stress in the pathophysiology of the dopaminergic system. Mol Psychiatry 5:14-21
27. Piazza PV, Le Moal ML (1996) Pathophysiological basis of vulnerability to drug abuse: role of an interaction between stress, glucocorticoids, and dopaminergic neurons. Annu Rev Pharmacol Toxicol 36:359-378
28. Piazza PV, Le Moal M (1997) Glucocorticoids as a biological substrate of reward: physiological and pathophysiological implications. Brain Res Brain Res Rev 25:359-372
29. Piazza PV, Deroche V, Deminiere JM, Maccari S, Le Moal M, Simon H (1993) Corticosterone in the range of stress-induced levels possesses reinforcing properties: implications for sensation-seeking behaviors. Proc Natl Acad Sci USA 90:11738-11742
30. Piazza PV, Rougé-Pont F, Deroche V, Maccari S, Simon H, Le Moal M (1996) Glucocorticoids have state-dependent stimulant effects on the mesencephalic dopaminergic transmission. Proc Natl Acad Sci USA 93:8716-8720
31. Porter RJ, Gallagher P, Watson S, Lunn BS, Young AH (2002) Effects of sub-chronic administration of hydrocortisone on hormonal and psychological responses to L-tryptophan in normal male volunteers. Psychopharmacology 163:68-75
32. Prasad BM, Sorg BA, Ulibarri C, Kalivas PW (1995) Sensitization to stress and psychostimulants - involvement of dopamine transmission versus the HPA axis. Ann N Y Acad Sci 771:617-625
33. Roth RH, Wolf ME, Deutch AY (1987) Neurochemistry of midbrain dopamine systems. In: Meltzer HY (ed) Psychopharmacology: the third generation of progress. Raven Press, New York, pp 81-94
34. 2 receptors. J Neurosci 22:3293-3301
35. Shaham Y, Stewart J (1994) Exposure to mild stress enhances the reinforcing efficacy of intravenous heroin self-administration in rats. Psychopharmacology 114:523-527
36. Shaham Y, Funk D, Erb S, Brown TJ, Walker CD, Stewart J (1997) Corticotropin-releasing factor, but not corticosterone, is involved in stress-induced relapse to heroin-seeking in rats. J Neurosci 17:2605-2614
37. Slattum PW, Venitz J, Barr WH (1996a) Comparison of methods for the assessment of central nervous system stimulant response after dextroamphetamine administration to healthy male volunteers. J Clin Pharmacol 36:1039-1050
38. Smit HJ, Rogers PJ (2002) Effects of "energy" drinks on mood and mental performance: critical methodology. Food Quality Preference 13:317-326
39. SPSS (1998) SPSS for Windows version 9. SPSS Inc.
40. Stewart J (2000) Pathways to relapse: the neurobiology of drug-and stress-induced relapse to drug-taking. J Psychiatr Neurosci 25:125-136
41. Wachtel SR, Charnot A, de Wit H (2001) Acute hydrocortisone administration does not affect subjective responses to d-amphetamine in humans. Psychopharmacology 153:380-388
42. Watson S, Porter RJ, Young AH (2000) Effect of hydrocortisone on the pituitary response to growth hormone releasing hormone. Psychopharmacology 152:40-46
43. Wise RA, Rompre PP (1989) Brain dopamine and reward. Annu Rev Psychol 40:191-225
44. Wong ML, Kling MA, Munson PJ, Listwak S, Licinio J, Prolo P, Karp B, McCutcheon IE, Geracioti TD, DeBellis MD, Rice KC, Goldstein DS, Veldhuis JD, Chrousos GP, Oldfield EH, McCann SM, Gold PW (2000) Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone. Proc Natl Acad Sci USA 97:325-330
45. Yeomans MR, Ripley T, Davies LH, Rusted JM, Rogers PJ (2002) Effects of caffeine on performance and mood depend on the level of caffeine abstinence. Psychopharmacology 164:241-249
46. Young AH, Sharpley AL, Campling GM, Hockney RA, Cowen PJ (1994) Effects of hydrocortisone on brain 5-HT function and sleep. J Affect Disord 32:139-146
47. Young AH, Rue J, Odontiadis J, Cowen PJ (1998) Lack of effect of hydrocortisone treatment on d-fenfluramine-mediated prolactin release. Psychopharmacology 136:198-200